Actavis Reports Record Profits and EBITDA Margins in Third Quarter
November 14, 2005 16:11 ET
|
Actavis
REYKJAVIK, Iceland, Nov. 14, 2005 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announces its results for the third quarter ended 30 September...
Svafa Gronfeldt Appointed Deputy to the CEO of Actavis Group
October 11, 2005 05:44 ET
|
Actavis
REYKJAVIK, Iceland, Oct. 11, 2005 (PRIMEZONE) -- Svafa Gronfeldt has been appointed Deputy to the CEO of Actavis Group. Svafa joined Actavis in 2004 as Chief Executive of Strategy and Organisational...
Actavis Acquires Keri Pharma Generics as Part of its Expansion Strategy in the CEE region
September 30, 2005 06:19 ET
|
Actavis
REYKJAVIK, Iceland, Sept. 30, 2005 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceutical company, today announces that it has acquired the generic business of the...
Actavis' Subsidiary Amide Receives FDA approval for Mirtazapine ODT
September 05, 2005 07:45 ET
|
Actavis
REYKJAVIK, Iceland, Sept. 5, 2005 (PRIMEZONE) -- Actavis Group hf.("ACT") today announces that Amide Pharmaceutical Inc., a subsidiary of Actavis Group in New Jersey USA, has received approval from...
The Actavis Group: Organisational Changes in Sales & Marketing International
August 30, 2005 09:34 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 30, 2005 (PRIMEZONE) -- The Actavis Group today announces that it has made organizational changes within its Sales and Marketing International division (Own-label sales) and...
Mark Keatley Appointed as Actavis Group's Chief Executive of Finance
August 10, 2005 10:08 ET
|
Actavis
REYKJAVIK, Iceland, Aug. 10, 2005 (PRIMEZONE) -- Actavis Group hf. ("ACT") announces today that Mark Keatley has been appointed as Chief Executive of Finance of the Actavis Group from 1 September and...
Actavis Reports Net Profits of EUR 22.4 Million for 1H 2005
August 09, 2005 15:46 ET
|
Actavis
HAFNARFIRDHI, Iceland, Aug. 9, 2005 (PRIMEZONE) -- Actavis Group hf. ("ACT"), the international generic pharmaceuticals company, announces its results for the quarter ended 30 June 2005.
Highlights...